In our new feature, TIMI Chairman Dr. Marc Sabatine discusses exciting trial results with TIMI Investigators
Dr. Erin Bohula, PI of the VESALIUS-CV (TIMI 66) trial, discusses the groundbreaking results presented at AHA25.
Dr. Sabatine discusses the CORE (TIMI 72a) and CORE2 CS6-TIMI 72b AHA 25 LBCT results and olezarsen’s impact on hypertriglyceridemia and pancreatitis with Dr. Nick Marston